<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Mon, 07 Sep 2026 11:33:05 -0400--><rss version="2.0">
    <channel>
        <title>Virax Biolabs Group Limited () SEC Filings</title>
        <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/rss</link>
        <description>Virax Biolabs Group Limited () - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png</url>
                <title>Virax Biolabs Group Limited Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[EFFECT - Notice of Effectiveness]]></title>
                <description><![CDATA[EFFECT]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/9999999995-26-002878/9999999995-26-002878.pdf</link>
                <pubDate>Fri, 04 Sep 26 06:04:37 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/9999999995-26-002878/9999999995-26-002878.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]></title>
                <description><![CDATA[2 Related Documents: 6-K, EX-5.1]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-383683/0001193125-26-383683.pdf</link>
                <pubDate>Fri, 04 Sep 26 16:20:33 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-383683/0001193125-26-383683.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B5 - Prospectus [Rule 424(b)(5)]]]></title>
                <description><![CDATA[424B5]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-383658/0001193125-26-383658.pdf</link>
                <pubDate>Fri, 04 Sep 26 16:11:27 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-383658/0001193125-26-383658.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[F-3/A - Registration statement by foreign private issuers]]></title>
                <description><![CDATA[4 Related Documents: F-3/A, EX-3.2, EX-5.1, EX-23.1]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-380474/0001193125-26-380474.pdf</link>
                <pubDate>Wed, 02 Sep 26 17:24:21 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-380474/0001193125-26-380474.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]></title>
                <description><![CDATA[6-K]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-368710/0001193125-26-368710.pdf</link>
                <pubDate>Wed, 26 Aug 26 16:30:50 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-368710/0001193125-26-368710.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]></title>
                <description><![CDATA[6-K]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-354722/0001193125-26-354722.pdf</link>
                <pubDate>Tue, 18 Aug 26 07:31:20 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-354722/0001193125-26-354722.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]></title>
                <description><![CDATA[4 Related Documents: 6-K, EX-99.1, EX-99.2, EX-99.3]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-326851/0001193125-26-326851.pdf</link>
                <pubDate>Fri, 31 Jul 26 07:45:14 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-326851/0001193125-26-326851.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[F-3 - Registration statement by foreign private issuers]]></title>
                <description><![CDATA[4 Related Documents: F-3, EX-5.1, EX-23.1, EX-FILING FEES]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-316130/0001193125-26-316130.pdf</link>
                <pubDate>Fri, 24 Jul 26 16:21:44 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-316130/0001193125-26-316130.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]></title>
                <description><![CDATA[2 Related Documents: 6-K, EX-99.1]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-305400/0001193125-26-305400.pdf</link>
                <pubDate>Thu, 16 Jul 26 07:32:02 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-305400/0001193125-26-305400.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]></title>
                <description><![CDATA[7 Related Documents: 6-K, EX-4.1, EX-4.2, EX-4.3, EX-10.1, EX-99.1, EX-99.2]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-300880/0001193125-26-300880.pdf</link>
                <pubDate>Fri, 10 Jul 26 16:07:31 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-300880/0001193125-26-300880.pdf</guid>
                                                                            </item>
            </channel>
</rss>